A Multicenter, Double-Blinded, Randomized, Placebo Controlled Study to Investigate the Safety and Immunogenicity of VAX102 When Given in the Same Arm With the Standard Influenza Vaccine in Healthy Adults.

Trial Profile

A Multicenter, Double-Blinded, Randomized, Placebo Controlled Study to Investigate the Safety and Immunogenicity of VAX102 When Given in the Same Arm With the Standard Influenza Vaccine in Healthy Adults.

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2014

At a glance

  • Drugs VAX 102 (Primary) ; Influenza virus vaccine
  • Indications Influenza A virus infections; Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors VaxInnate
  • Most Recent Events

    • 06 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 23 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top